{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T04:55:53Z","timestamp":1775537753097,"version":"3.50.1"},"reference-count":59,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T00:00:00Z","timestamp":1762992000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T00:00:00Z","timestamp":1762992000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Innovation Team and Talents Cultivation Program of National Administration of Traditional Chinese Medicine","award":["ZYYCXTD-D-202207"],"award-info":[{"award-number":["ZYYCXTD-D-202207"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82103776"],"award-info":[{"award-number":["82103776"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"the Youth Independent Innovation Science Fund Project of Chinese PLA General Hospital","award":["22QNCZ009"],"award-info":[{"award-number":["22QNCZ009"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Mol Biol Lett"],"DOI":"10.1186\/s11658-025-00821-8","type":"journal-article","created":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T18:40:59Z","timestamp":1763059259000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["E0703 targets ER\u03b2 to facilitate the upregulation of GLI3, thereby alleviating irradiation-induced DNA damage on lymphocytes"],"prefix":"10.1186","volume":"30","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5677-7052","authenticated-orcid":false,"given":"Zebin","family":"Liao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liangliang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zekun","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Changkun","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xianglin","family":"Tang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chengrong","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liren","family":"Qian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yue","family":"Gao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,11,13]]},"reference":[{"key":"821_CR1","doi-asserted-by":"crossref","unstructured":"Christine A, Sohyoung H, David AJ. Radiotherapy for cancer: present and future. Adv Drug Deliv Rev. 2017;109(0).","DOI":"10.1016\/j.addr.2017.01.004"},{"key":"821_CR2","doi-asserted-by":"crossref","unstructured":"Jingjing L, Qingqing C, Zhengcao L, Yingying X, Shengjun J. Predictive value of bowel dose-volume for severe radiation-induced lymphopenia and survival in cervical cancer. Front Immunol. 2024;15(0).","DOI":"10.3389\/fimmu.2024.1459206"},{"key":"821_CR3","doi-asserted-by":"crossref","unstructured":"Sebastian T, Jungwook S, Cornelia H, Wonmo S. Correlation of dynamic blood dose with clinical outcomes in radiotherapy for head-and-neck cancer. Radiother Oncol. 2024;202(0).","DOI":"10.1016\/j.radonc.2024.110603"},{"key":"821_CR4","doi-asserted-by":"crossref","unstructured":"Gohar SM, Susan YW, Stephanie OD, Elaine EC, Alison KY, Kelsey LC, et al. Characterization of lymphopenia and correlating the risk of cytopenias with dose and bone marrow volume irradiated in aggressive B cell lymphoma patients bridged with radiation therapy for chimeric antigen receptor-T cell therapy. Int J Radiat Oncol Biol Phys. 2024;121(4).","DOI":"10.1016\/j.ijrobp.2024.09.023"},{"key":"821_CR5","doi-asserted-by":"crossref","unstructured":"Subhajit G, Jiayi H, Matthew I, Jin Z, Sukrutha T, Ekaterina T, et al. Radiation-induced circulating myeloid-derived suppressor cells induce systemic lymphopenia after chemoradiotherapy in patients with glioblastoma. Sci Transl Med. 2023;15(680).","DOI":"10.1126\/scitranslmed.abn6758"},{"key":"821_CR6","doi-asserted-by":"crossref","unstructured":"Michael TM, Mahadevappa M, Fred AM, Jennifer E, Richard JV. Patient radiation exposure: imaging during radiation oncology procedures: executive summary of NCRP report no. 184. J Am Coll Radiol. 2020;17(9).","DOI":"10.1016\/j.jacr.2020.02.002"},{"key":"821_CR7","doi-asserted-by":"crossref","unstructured":"Marija ZR, Neda M, Tatjana BM, Slobodan J, Marko F. Review of compounds that exhibit radioprotective and\/or mitigatory effects after application of diagnostic or therapeutic ionizing radiation. Int J Radiat Biol. 2022;99(4).","DOI":"10.1080\/09553002.2022.2110308"},{"key":"821_CR8","doi-asserted-by":"crossref","unstructured":"Yuting Y, Jinlong Y, Jianwei Z, Xingyu C, Li Z, Wenjuan M, et al. A DNA tetrahedron-based nanosuit for efficient delivery of amifostine and multi-organ radioprotection. Bioact Mater. 2024;39(0).","DOI":"10.1016\/j.bioactmat.2024.05.017"},{"key":"821_CR9","doi-asserted-by":"crossref","unstructured":"Sushil KS, Nitish KM, Neetha NV, Lynnette C, Tom\u00e1\u0161 H, Robert P, et al. A review of radiation-induced alterations of multi-omic profiles, radiation injury biomarkers, and countermeasures. Radiation Research. 2022;199(1).","DOI":"10.1667\/RADE-21-00187.1"},{"key":"821_CR10","doi-asserted-by":"crossref","unstructured":"Vijay KS, Thomas MS. Entolimod as a radiation countermeasure for acute radiation syndrome. Drug Discov Today. 2020;26(1).","DOI":"10.1016\/j.drudis.2020.10.003"},{"key":"821_CR11","doi-asserted-by":"crossref","unstructured":"Vijay KS, Thomas MS. A review of radiation countermeasures focusing on injury-specific medicinals and regulatory approval status: part I. Radiation sub-syndromes, animal models and FDA-approved countermeasures. Int J Radiat Biol. 2017;93(9).","DOI":"10.1080\/09553002.2017.1332438"},{"key":"821_CR12","doi-asserted-by":"crossref","unstructured":"Ming C, Huiwen X, Yuan L, Lixin Z, Shuyi Z, Dan L, et al. Faecal microbiota transplantation protects against radiation-induced toxicity. EMBO Mol Med. 2017;9(4).","DOI":"10.15252\/emmm.201606932"},{"key":"821_CR13","doi-asserted-by":"crossref","unstructured":"JST, ELS, MKC, CDS. Studies on the mechanisms of estradiol-induced radioprotection. Radiation Research. 1969;40(1).","DOI":"10.2307\/3572984"},{"key":"821_CR14","doi-asserted-by":"crossref","unstructured":"JST, RWR, MC, HPR. The effect of estradiol and estriol on the survival of sublethally and lethally irradiated mice. Radiation Research. 1965;26(4).","DOI":"10.2307\/3571867"},{"key":"821_CR15","doi-asserted-by":"crossref","unstructured":"GW, MK, MLM. Hormone pretreatment enhances recovery of spermatogenesis in rats after neutron irradiation. Radiation Research. 1999;152(1).","DOI":"10.2307\/3580048"},{"key":"821_CR16","doi-asserted-by":"crossref","unstructured":"Maria A ZZ, Laura RG, Damian GM, Lucila GC, Hugo R, Luis MZ, et al. Partial neuroprotection by 17-\u03b2-estradiol in neonatal \u03b3-irradiated rat cerebellum. Neurochem Int. 2010;58(3).","DOI":"10.1016\/j.neuint.2010.11.020"},{"key":"821_CR17","doi-asserted-by":"crossref","unstructured":"Joy G, Shailaja V, Marc SM, Robert MB, Jennifer L, Andrea C-G, et al. The Protective effect of estrogen against radiation cataractogenesis is dependent upon the type of radiation. Radiation Research. 2020;194(5).","DOI":"10.1667\/RADE-20-00015.1"},{"key":"821_CR18","unstructured":"Ji-Hee K, Jae-Kyung N, A-Ram K, Min-Sik P, Hae-June L, Joonho P, et al. 2-Methoxyestradiol inhibits radiation-induced skin injuries. Int J Mol Sci. 2022;23(8)."},{"key":"821_CR19","doi-asserted-by":"crossref","unstructured":"Yun-Xuan G, Zhuo Z, Jia-Yi Y, Zeng-Chun M, Yu-Guang W, Cheng-Rong X, et al. Prediction of human pharmacokinetics of E0703, a novel radioprotective agent, using physiologically based pharmacokinetic modeling and an interspecies extrapolation approach. Int J Mol Sci. 2024;25(5).","DOI":"10.3390\/ijms25053047"},{"key":"821_CR20","doi-asserted-by":"crossref","unstructured":"Jian L, Zhiyun M, Hui G, Ruolan G, Zhuona W, Guifang D, et al. Simultaneous quantitation of E0703, a novel radioprotective agent and its oxidative metabolite M1 in human plasma by UPLC-MS\/MS, and application to clinical pharmacokinetics. J Pharm Biomed Anal. 2019;174(0).","DOI":"10.1016\/j.jpba.2019.05.020"},{"key":"821_CR21","doi-asserted-by":"crossref","unstructured":"Brad RH, Thomas GC, Ning G, Ron LH, Dana RH, Stacey AJ, et al. A new series of estrogen receptor modulators that display selectivity for estrogen receptor beta. J Med Chem. 2002;45(25).","DOI":"10.1021\/jm020291h"},{"key":"821_CR22","unstructured":"Hui Wen N, Wenqian Z, Mao S, Heng L, Weigong G, Roger P, et al. Competitive molecular docking approach for predicting estrogen receptor subtype \u03b1 agonists and antagonists. BMC Bioinformatics. 2014(0)."},{"key":"821_CR23","doi-asserted-by":"crossref","unstructured":"Vijay KS, Briana KH, Paola TS, Thomas MS. A review of radiation countermeasures focusing on injury-specific medicinals and regulatory approval status: part III. Countermeasures under early stages of development along with \u201cstandard of care\u201d medicinal and procedures not requiring regulatory approval for use. Int J Radiat Biol. 2017;93(9).","DOI":"10.1080\/09553002.2017.1332440"},{"key":"821_CR24","doi-asserted-by":"crossref","unstructured":"Vijay KS, Melissa G, Thomas MS. A review of radiation countermeasures focusing on injury-specific medicinals and regulatory approval status: part II. Countermeasures for limited indications, internalized radionuclides, emesis, late effects, and agents demonstrating efficacy in large animals with or without FDA IND status. Int J Radiat Biol. 2017;93(9).","DOI":"10.1080\/09553002.2017.1338782"},{"key":"821_CR25","doi-asserted-by":"crossref","unstructured":"Juliann GK, Georgetta C, Vijay KS. An overview of radiation countermeasure development in radiation research from 1954 to 2024. Radiation Research. 2024;202(2).","DOI":"10.1667\/RADE-24-00036.1"},{"key":"821_CR26","doi-asserted-by":"crossref","unstructured":"Mari SG, Casey EH, Stacey LG, Bill LL, Kala N, Alice FT. Effects of exogenous estrogenic agents on pubertal growth and reproductive system maturation in female rhesus monkeys. Toxicol Sci. 2003;74(1).","DOI":"10.1093\/toxsci\/kfg090"},{"key":"821_CR27","doi-asserted-by":"crossref","unstructured":"Linda K, Geno AG, Taishi N, George AW, Helen MH, Annette MM, et al. Genetic predisposition to altered blood cell homeostasis is associated with glioma risk and survival. Nat Commun. 2025;16(1).","DOI":"10.1038\/s41467-025-55919-6"},{"key":"821_CR28","doi-asserted-by":"crossref","unstructured":"Sina T, Johannes D, Akira T, Olga H, Marika K, Heidi G, et al. Clever-1 contributes to lymphocyte entry into the spleen via the red pulp. Sci Immunol. 2019;4(33).","DOI":"10.1126\/sciimmunol.aat0297"},{"key":"821_CR29","doi-asserted-by":"crossref","unstructured":"Brendan M, David OL, Nermina S, Faiz A, Lynn SW, Le\u2019Mark R, et al. MYSM1 attenuates DNA damage signals triggered by physiologic and genotoxic DNA breaks. J Allergy Clin Immunol. 2023;153(4).","DOI":"10.1016\/j.jaci.2023.12.001"},{"key":"821_CR30","doi-asserted-by":"crossref","unstructured":"Kuo-Kuang W, Seong-Su H, Yatin MV. Wiskott-Aldrich syndrome protein senses irradiation-induced DNA damage to coordinate the cell-protective Golgi dispersal response in human T and B lymphocytes. J Allergy Clin Immunol. 2019;145(1).","DOI":"10.1016\/j.jaci.2019.09.026"},{"key":"821_CR31","doi-asserted-by":"crossref","unstructured":"Toshiaki N, Ken A, Masaoki K, Masataka T, Ryoichi H, Akira S, et al. Deciphering repair pathways of clustered DNA damage in human TK6 cells: insights from atomic force microscopy direct visualization. Nucleic Acids Res. 2025;53(1).","DOI":"10.1093\/nar\/gkae1077"},{"key":"821_CR32","doi-asserted-by":"crossref","unstructured":"Saurabh S, Prajwal G. A comprehensive review of sensors of radiation-induced damage, radiation-induced proximal events, and cell death. Immunol Rev. 2024;329(1).","DOI":"10.1111\/imr.13409"},{"key":"821_CR33","doi-asserted-by":"crossref","unstructured":"Bailin Z, Eli R, Dale A R, Michael R L. The molecular basis and disease relevance of non-homologous DNA end joining. Nat Rev Mol Cell Biol. 2020;21(12).","DOI":"10.1038\/s41580-020-00297-8"},{"key":"821_CR34","doi-asserted-by":"crossref","unstructured":"Andrew NB, Stephen PJ. ATM, ATR, and DNA-PK: the trinity at the heart of the DNA damage response. Mol Cell. 2017;66(6).","DOI":"10.1016\/j.molcel.2017.05.015"},{"key":"821_CR35","doi-asserted-by":"crossref","unstructured":"Rui-Xue H, Ping-Kun Z. DNA damage response signaling pathways and targets for radiotherapy sensitization in cancer. Signal Transduct Target Ther. 2020;5(1).","DOI":"10.1038\/s41392-020-0150-x"},{"key":"821_CR36","doi-asserted-by":"crossref","unstructured":"Dongfang W, Muya T, Peidong Z, Kailin Y, Liang H, Mengrui W, et al. Activation of ER\u03b2 hijacks the splicing machinery to trigger R-loop formation in triple-negative breast cancer. Proc Natl Acad Sci U S A. 2024;121(13).","DOI":"10.1073\/pnas.2306814121"},{"key":"821_CR37","doi-asserted-by":"crossref","unstructured":"Mei Z, Gangadhara RS, Mengxing L, Jinyou L, Yiliao L, Prabhakar Pitta V, et al. Estrogen receptor beta enhances chemotherapy response of GBM cells by down regulating DNA damage response pathways. Sci Rep. 2019;9(1).","DOI":"10.1038\/s41598-019-42313-8"},{"key":"821_CR38","doi-asserted-by":"crossref","unstructured":"Margaret W, Bo H, Jan-Ake G. Estrogen receptor \u03b2 as a pharmaceutical target. Trends Pharmacol Sci. 2016;38(1).","DOI":"10.1016\/j.tips.2016.10.006"},{"key":"821_CR39","doi-asserted-by":"crossref","unstructured":"Joshua D S, Kyuri K, Tze Howe C, Barry K, Ken C N C, W Lee K, et al. Genome-wide analysis of estrogen receptor alpha DNA binding and tethering mechanisms identifies Runx1 as a novel tethering factor in receptor-mediated transcriptional activation. Mol Cell Biol. 2010;30(16).","DOI":"10.1128\/MCB.00118-10"},{"key":"821_CR40","doi-asserted-by":"crossref","unstructured":"Stefan N, Konrad FK, Jan-\u00c5ke G. Development of subtype-selective oestrogen receptor-based therapeutics. Nat Rev Drug Discov. 2011;10(10).","DOI":"10.1038\/nrd3551"},{"key":"821_CR41","doi-asserted-by":"crossref","unstructured":"Binita C, Jovita B, Taylor K, Felicia L, Ching-Yi C, Donald P M. Estrogen receptor signaling in the immune system. Endocr Rev. 2022;44(1).","DOI":"10.1210\/endrev\/bnac017"},{"key":"821_CR42","doi-asserted-by":"crossref","unstructured":"Michael RL, Adam JH, Michael DK, Regina MD. Mechanism and therapeutic window of a genistein nanosuspension to protect against hematopoietic-acute radiation syndrome. J Radiat Res. 2019;60(3).","DOI":"10.1093\/jrr\/rrz014"},{"key":"821_CR43","doi-asserted-by":"crossref","unstructured":"Yasmin Hamdy H, Riham SS, Rehab K, Engy M El M, Ebtehal E-D. Phytoestrogen genistein hinders ovarian oxidative damage and apoptotic cell death-induced by ionizing radiation: co-operative role of ER-\u03b2, TGF-\u03b2, and FOXL-2. Sci Rep. 2020;10(1).","DOI":"10.1038\/s41598-020-70309-2"},{"key":"821_CR44","doi-asserted-by":"crossref","unstructured":"Parvesh C, Mohan S, Timothy JT, Monica G, Akil AM. GLI3 repressor determines Hedgehog pathway activation and is required for response to SMO antagonist glasdegib in AML. Blood. 2017;129(26).","DOI":"10.1182\/blood-2016-05-718585"},{"key":"821_CR45","doi-asserted-by":"crossref","unstructured":"Rachel KL, Weiqiang Z, Zhicheng J, Kristin NF, Kaleigh ES, Kathryn EW, et al. GLI transcriptional repression is inert prior to Hedgehog pathway activation. Nat Commun. 2022;13(1).","DOI":"10.1038\/s41467-022-28485-4"},{"key":"821_CR46","doi-asserted-by":"crossref","unstructured":"Ariadne LH-T, Johannes TD, Susan VO, Tessa C. The transcription factor Gli3 regulates differentiation of fetal CD4- CD8- double-negative thymocytes. Blood. 2005;106(4).","DOI":"10.1182\/blood-2005-03-0998"},{"key":"821_CR47","doi-asserted-by":"crossref","unstructured":"Anisha S, Ching-In L, Jos\u00e9 Ignacio S, Susan R, Tessa C. The transcription factor Gli3 promotes B cell development in fetal liver through repression of Shh. J Exp Med. 2017;214(7).","DOI":"10.1084\/jem.20160852"},{"key":"821_CR48","unstructured":"Anisha S, Diana CY, Susan R, Ching-In L, Eleftheria P, Jiawei L, et al. Gli3 in fetal thymic epithelial cells promotes thymocyte positive selection and differentiation by repression of Shh. Development. 2018;145(3)."},{"key":"821_CR49","doi-asserted-by":"crossref","unstructured":"Tapati M, Jennifer D, Akwasi A, Ting S, Janet AH. Blocking Hedgehog survival signaling at the level of the GLI genes induces DNA damage and extensive cell death in human colon carcinoma cells. Cancer Res. 2011;71(17).","DOI":"10.1158\/0008-5472.CAN-10-4173"},{"key":"821_CR50","doi-asserted-by":"crossref","unstructured":"Jason SW, Bulat F, Kishan RP, Alison MK, Seren MP, David JG, et al. FAM122A ensures cell cycle interphase progression and checkpoint control by inhibiting B55\u03b1\/PP2A through helical motifs. Nat Commun. 2024;15(1).","DOI":"10.1038\/s41467-024-50015-7"},{"key":"821_CR51","doi-asserted-by":"crossref","unstructured":"Jack L, Jill EH, Amy C, Amelia R, Lauren GR, Erik R-G, et al. c-Rel-dependent Chk2 signaling regulates the DNA damage response limiting hepatocarcinogenesis. Hepatology. 2022;78(4).","DOI":"10.1002\/hep.32781"},{"key":"821_CR52","doi-asserted-by":"crossref","unstructured":"Daipayan B, Kurt L, Salar A, Eric O, Praveen Y, Martin V, et al. A non-canonical, interferon-independent signaling activity of cGAMP triggers DNA damage response signaling. Nat Commun. 2021;12(1).","DOI":"10.1038\/s41467-021-26240-9"},{"key":"821_CR53","doi-asserted-by":"crossref","unstructured":"Ora H, Urmila S, Ana T-BH, Anat B, Anna U, Alexander W, et al. Dynamic interaction of eukaryotic initiation factor 4G1 (eIF4G1) with eIF4E and eIF1 underlies scanning-dependent and -independent translation. Mol Cell Biol. 2018;38(18).","DOI":"10.1128\/MCB.00139-18"},{"key":"821_CR54","doi-asserted-by":"crossref","unstructured":"Jun W, Lijun W, Shuhong Z, Junting F, Hui Y, Qiqi L, et al. Novel eIF4E\/eIF4G protein-protein interaction inhibitors DDH-1 exhibits anti-cancer activity in vivo and in vitro. Int J Biol Macromol. 2020;160(0).","DOI":"10.1016\/j.ijbiomac.2020.05.233"},{"key":"821_CR55","doi-asserted-by":"crossref","unstructured":"Regina C, David RH, Francis R, Yuhong D, Jaeki M, Lian L, et al. Reversing chemoresistance by small molecule inhibition of the translation initiation complex eIF4F. Proc Natl Acad Sci U S A. 2010;108(3).","DOI":"10.1073\/pnas.1104339108"},{"key":"821_CR56","doi-asserted-by":"crossref","unstructured":"Sai H, Dafei X, Pingkun Z, Xiaodan L, Xiaoyao Y, Bo H, et al. LINCS gene expression signature analysis revealed bosutinib as a radiosensitizer of breast cancer cells by targeting eIF4G1. Int J Mol Med. 2021;47(5).","DOI":"10.3892\/ijmm.2021.4905"},{"key":"821_CR57","doi-asserted-by":"crossref","unstructured":"Michelle B, Steve B, Jiri Z, Robert JS. DNA damage and eIF4G1 in breast cancer cells reprogram translation for survival and DNA repair mRNAs. Proc Natl Acad Sci U S A. 2012;109(46).","DOI":"10.1073\/pnas.1203853109"},{"key":"821_CR58","doi-asserted-by":"crossref","unstructured":"Gayatri M, Raju R, H\u00e9l\u00e8ne M-M, Swati L, Lucilla F, Sidhant K, et al. Genotoxic stress triggers Scd6-dependent regulation of translation to modulate the DNA damage response. EMBO Rep. 2025;26(10).","DOI":"10.1038\/s44319-025-00443-3"},{"key":"821_CR59","doi-asserted-by":"crossref","unstructured":"Yongmei F, Anthony B P, Laura H, Tongwu Z, Michael A D, Stefan G, et al. SBI-0640756 attenuates the growth of clinically unresponsive melanomas by disrupting the eIF4F translation initiation complex. Cancer Res. 2015;75(24).","DOI":"10.1158\/0008-5472.CAN-15-0885"}],"container-title":["Cellular &amp; Molecular Biology Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s11658-025-00821-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s11658-025-00821-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s11658-025-00821-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T18:41:09Z","timestamp":1763059269000},"score":1,"resource":{"primary":{"URL":"https:\/\/cmbl.biomedcentral.com\/articles\/10.1186\/s11658-025-00821-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,13]]},"references-count":59,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["821"],"URL":"https:\/\/doi.org\/10.1186\/s11658-025-00821-8","relation":{},"ISSN":["1689-1392"],"issn-type":[{"value":"1689-1392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,13]]},"assertion":[{"value":"8 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All animal experiments were approved by the animal laboratory of Laboratory Animal Center of Beijing Institute of Radiation Medicine (IACUC-DWZX-2021-557, 3 March 2021). Clinical trial: not applicable. The animal laboratory of Laboratory Animal Center of Beijing Institute of Radiation Medicine acts in accordance with the International Council for Laboratory Animal Science (ICLAS).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors read and approved the final manuscript.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"136"}}